A Month After Lung Cancer Withdrawal, Takeda Gets Approval For New Colorectal Cancer Drug

Takeda announced the approval of Fruzaqla in previously treated metastatic colorectal cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip